Annual Accounts Payable
$337.00 K
-$6.81 M-95.28%
December 31, 2023
Summary
- As of February 7, 2025, NMRA annual accounts payable is $337.00 thousand, with the most recent change of -$6.81 million (-95.28%) on December 31, 2023.
- During the last 3 years, NMRA annual accounts payable has fallen by -$2.06 million (-85.95%).
- NMRA annual accounts payable is now -95.28% below its all-time high of $7.15 million, reached on December 31, 2022.
Performance
NMRA Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$6.11 M
+$5.03 M+464.42%
September 30, 2024
Summary
- As of February 7, 2025, NMRA quarterly accounts payable is $6.11 million, with the most recent change of +$5.03 million (+464.42%) on September 30, 2024.
- Over the past year, NMRA quarterly accounts payable has increased by +$4.62 million (+309.32%).
- NMRA quarterly accounts payable is now -25.27% below its all-time high of $8.17 million, reached on June 30, 2023.
Performance
NMRA Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
NMRA Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -95.3% | +309.3% |
| 3 y3 years | -86.0% | +102.5% |
| 5 y5 years | +100.0% | +102.5% |
NMRA Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -95.3% | at low | -25.3% | +1712.2% |
| 5 y | 5-year | -95.3% | -100.0% | -25.3% | +1712.2% |
| alltime | all time | -95.3% | -100.0% | -25.3% | +1712.2% |
Neumora Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $6.11 M(+464.4%) |
| Jun 2024 | - | $1.08 M(-27.5%) |
| Mar 2024 | - | $1.49 M(+342.7%) |
| Dec 2023 | $337.00 K(-95.3%) | $337.00 K(-84.9%) |
| Sep 2023 | - | $2.23 M(-72.7%) |
| Jun 2023 | - | $8.17 M(+14.3%) |
| Dec 2022 | $7.15 M | $7.15 M(+137.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $3.02 M(+83.1%) |
| Mar 2022 | - | $1.65 M(+0.5%) |
| Dec 2021 | $1.64 M(-31.7%) | - |
| Dec 2021 | - | $1.64 M(-34.6%) |
| Sep 2021 | - | $2.51 M(+4.6%) |
| Dec 2020 | $2.40 M(>+9900.0%) | $2.40 M |
| Dec 2019 | $0.00 | - |
FAQ
- What is Neumora Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Neumora Therapeutics?
- What is Neumora Therapeutics annual accounts payable year-on-year change?
- What is Neumora Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Neumora Therapeutics?
- What is Neumora Therapeutics quarterly accounts payable year-on-year change?
What is Neumora Therapeutics annual accounts payable?
The current annual accounts payable of NMRA is $337.00 K
What is the all time high annual accounts payable for Neumora Therapeutics?
Neumora Therapeutics all-time high annual accounts payable is $7.15 M
What is Neumora Therapeutics annual accounts payable year-on-year change?
Over the past year, NMRA annual accounts payable has changed by -$6.81 M (-95.28%)
What is Neumora Therapeutics quarterly accounts payable?
The current quarterly accounts payable of NMRA is $6.11 M
What is the all time high quarterly accounts payable for Neumora Therapeutics?
Neumora Therapeutics all-time high quarterly accounts payable is $8.17 M
What is Neumora Therapeutics quarterly accounts payable year-on-year change?
Over the past year, NMRA quarterly accounts payable has changed by +$4.62 M (+309.32%)